ロード中...
Prevention of β Thalassemia in Northern Israel - a Cost-Benefit Analysis
BACKGROUND: β Thalassemia major is characterized by hemolytic anemia, ineffective erythropoiesis and hemosiderosis. About 4% of the world population carries a Thalassemia gene. Management includes blood transfusions and iron chelation. However, this treatment is costly, and population screening may...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Università Cattolica del Sacro Cuore
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3965716/ https://ncbi.nlm.nih.gov/pubmed/24678389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2014.012 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|